Director and Chief, Division of Abdominal Surgical Oncology, Hepatobiliary and pancreatic section, Department of Surgical Oncology
National Cancer Institute of Naples, Fondazione “G. Pascale”, Italy
Francesco Izzo, M.D.
Surgical Oncologist and Oncologist, 06/05/1965, Naples Italy; life partner Giulia Di Capua, children Francesca and Ginevra
Dr. Francesco Izzo received his medical degree from the University of Naples, Federico II Medical School, Italy. He completed a general surgery residency at the University of Naples, Italy and then completed a fellowship in Surgical Oncology at the University of Texas Anderson Cancer Center. Dr. Izzo has been on the faculty in the Department of Surgical Oncology at the National Cancer Institute of Naples, Italy since completing his fellowship. He is now Associate Professor of Surgery, Responsible and Coordinator of the Hepatobiliary Surgery and chief of Liver Tumor Study Group at the National Cancer Institute of Naples, Italy.
Dr. Izzo’s clinical practice and research focuses on surgical new treatments for patients with primary or metastatic liver tumors.
Dr. Izzo has been a pioneer in designing new treatments for patients with liver tumors, including radiofrequency ablation, improved techniques for surgical removal of liver cancers, and several types of direct tumor injection therapy.
Dr Izzo is principal investigator on a number of National and International protocols for the basic science and clinical treatment on primary and metastatic hepatobiliary cancers
Dr. Izzo is the author or co-author of over 205 publications, 20 book chapters, many dealing with the treatment of patients with hepatocellular cancer, gallbladder cancer, bile duct cancer, or metastases from a number of different tumor types
Hepatocellular cancer, gallbladder cancer, bile duct cancer, or metastases from a number of different tumor types.